academic article

• Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer..  Lung cancer (Amsterdam, Netherlands).  40:91-97. 2003
• Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  20:1335-1343. 2002